Aktivieren Sie Javascript in Ihrem Browser, um unsere Webseite optimal zu nutzen.

VEGFR2/CD309 Antikörper (Extracellular Domain)

VEGFR2 Reaktivität: Human WB, IHC (fro) Wirt: Maus Monoclonal FLK-6 unconjugated

Produktnummer ABIN2154574

Datenblatt (PDF)

Target Alle VEGFR2/CD309 (VEGFR2) Antikörper anzeigen

VEGFR2/CD309 (VEGFR2) (VEGF Receptor 2 (VEGFR2))
Bindungsspezifität
37

34

27

23

20

16

11

10

9

8

8

6

5

5

5

4

3

3

3

2

2

2

2

2

2

2

2

2

2

2

2

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1
Extracellular Domain
Reaktivität
293

184

128

9

5

3

3

3

3

1

1

1

1

1

1

1

1

1

1

1
Human
Wirt
274

59

24

1

1

1
Maus
Passende Sekundärantikörper
Klonalität
266

94
Monoklonal
Konjugat
165

30

18

13

10

9

9

7

7

7

7

7

5

5

5

5

5

5

5

5

5

5

5

3

2

2

2

1

1

1

1

1

1

1
Dieser VEGFR2/CD309 Antikörper ist unkonjugiert
Applikation
213

117

98

85

64

25

24

18

13

13

10

9

7

7

7

4

3

2

2

2

2

1

1

1
Western Blotting (WB), Immunohistochemistry (Frozen Sections) (IHC (fro))

Immunogen

VEGFR2 antibody was raised in mouse using recombinant human extracellular domain of VEGFR-2 (KDR) as the immunogen

Klon

FLK-6

Isotyp

IgG1

Top Product

Discover our top product VEGFR2 Primärantikörper
anti-VEGF Receptor 2 (VEGFR2) (AA 20-200) antibody
VEGFR2 Reaktivität: Human WB, IHC Wirt: Kaninchen Polyclonal unconjugated

anti-VEGF Receptor 2 (VEGFR2) (AA 1326-1356), (C-Term) antibody
VEGFR2 Reaktivität: Human WB, FACS, IF, IHC (p) Wirt: Kaninchen Polyclonal RB01536 unconjugated

anti-VEGF Receptor 2 (VEGFR2) (pTyr951) antibody
VEGFR2 Reaktivität: Human, Maus, Ratte WB, IHC, ELISA, IF, ICC Wirt: Kaninchen Polyclonal unconjugated

anti-VEGF Receptor 2 (VEGFR2) (AA 20-242) antibody
VEGFR2 Reaktivität: Human WB, IHC (p) Wirt: Kaninchen Polyclonal unconjugated

anti-VEGF Receptor 2 (VEGFR2) (AA 1326-1356) antibody
VEGFR2 Reaktivität: Human WB, IHC, ELISA, FACS, IF Wirt: Kaninchen Polyclonal unconjugated

anti-VEGF Receptor 2 (VEGFR2) (AA 20-764) antibody
VEGFR2 Reaktivität: Human ELISA, FACS, ICC Wirt: Maus Monoclonal 4B4 unconjugated

anti-VEGF Receptor 2 (VEGFR2) (AA 1225-1356) antibody
VEGFR2 Reaktivität: Human ELISA, FACS Wirt: Maus Monoclonal 1A9A3 unconjugated

anti-VEGF Receptor 2 (VEGFR2) (pTyr1214) antibody
VEGFR2 Reaktivität: Human, Maus, Ratte WB, IHC, ELISA, IF, ICC Wirt: Kaninchen Polyclonal unconjugated

anti-VEGF Receptor 2 (VEGFR2) (AA 454-469), (Middle Region) antibody
VEGFR2 Reaktivität: Human WB, IHC (p), ICC, IHC (fro) Wirt: Kaninchen Polyclonal unconjugated

anti-VEGF Receptor 2 (VEGFR2) (AA 46-320) antibody
VEGFR2 Reaktivität: Ratte WB, IHC, IP, ICC Wirt: Kaninchen Polyclonal unconjugated

Applikationshinweise

Optimal conditions to be determined by the end user

Beschränkungen

Nur für Forschungszwecke einsetzbar
Format

Lyophilized

Konzentration

Lot specific

Buffer

lyophilized form

Handhabung

Avoid repeated freeze/thaw cycles

Lagerung

-20 °C

Informationen zur Lagerung

Store at 4 °C for short term storage. For long term storage aliquot and store at -20 °C,
Target

VEGFR2/CD309 (VEGFR2) (VEGF Receptor 2 (VEGFR2))

Andere Bezeichnung

VEGFR2 (VEGFR2 Produkte)

Pathways

RTK Signalweg, Glycosaminoglycan Metabolic Process, Signaling Events mediated by VEGFR1 and VEGFR2, Growth Factor Binding, Regulation of long-term Neuronal Synaptic Plasticity, VEGF Signaling